2022
DOI: 10.1111/pan.14602
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of intravenous and inhalation anesthesia on postoperative behavior changes in children undergoing ambulatory endoscopic procedures: A randomized clinical trial

Abstract: Background Early and delayed behavioral changes are well recognized after anesthesia. Intravenous anesthesia may prevent emergence delirium. However, it has not been evaluated as a preventive strategy for delayed postoperative behavior changes. Aims We aimed to determine whether intravenous anesthesia is effective at reducing postoperative behavior changes in children undergoing ambulatory endoscopic procedures when compared to inhalation anesthesia. Methods This randomized, double‐blinded controlled trial was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
0
0
Order By: Relevance
“…In this study, the incidence of NPOBCs in children treated with esketamine was lower than in those treated with sevoflurane inhalation alone. Esketamine, as an NMDA receptor antagonist, may exert analgesic effects after use, reduce glutamate excitotoxicity and microglial activity, and inhibit the production of inflammatory cytokines and neuronal apoptosis to exert neuroprotective effects (26), thereby decreasing the incidence rate of NPOBCs. Nonetheless, the children receiving 0.5 and 0.75 mg/kg esketamine had similar incidence rates of NPOBCs, suggesting that both doses had neuroprotective effects.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, the incidence of NPOBCs in children treated with esketamine was lower than in those treated with sevoflurane inhalation alone. Esketamine, as an NMDA receptor antagonist, may exert analgesic effects after use, reduce glutamate excitotoxicity and microglial activity, and inhibit the production of inflammatory cytokines and neuronal apoptosis to exert neuroprotective effects (26), thereby decreasing the incidence rate of NPOBCs. Nonetheless, the children receiving 0.5 and 0.75 mg/kg esketamine had similar incidence rates of NPOBCs, suggesting that both doses had neuroprotective effects.…”
Section: Discussionmentioning
confidence: 99%